2028年までの中東およびアフリカの放射性医薬品市場予測 – 新型コロナウイルス感染症の影響と地域分析（タイプ別（診断用核医学および治療用核医学）、アプリケーション（腫瘍学、心臓病学、神経学など）、およびエンドユーザー（病院、画像センター、医療センター）学術研究センター等）

市場紹介

MEA 放射性医薬品市場は、サウジアラビア、UAE、南アフリカ、および MEA の残りの地域に基づいて分析されます。サウジアラビアは地域最大の市場の一つです。サウジアラビア王国（KSA）では脳卒中の有病率が大幅に増加しており、サウジアラビアにおける病気と死亡の重要な原因となっている。しかし、脳卒中の発生率、有病率、および社会人口学的特性に関する研究は、先進国に比べてまだ不十分です。認識の欠如は、これらの特定の分野で適切な研究が実施されていないことが原因であると予想されます。脳卒中はサウジアラビアで急速に増加している問題であり、病気と死亡の主な原因となっている。しかし、先進国と比較すると、脳卒中の発生率、有病率、社会人口学的特徴に関する研究は、これらの分野で十分な研究が不足しているため、依然として不足しています。アラブ人の間では、脳卒中危険因子の大部分は高血圧や糖尿病などの修正可能な既知の因子です。脳卒中による死亡のリスクは年齢とともに上昇し、脳出血による死亡のリスクも高くなります。若年性脳卒中は全脳卒中のうち 6 ～ 20% を占めます。放射性医薬品関連施設の増加と慢性疾患の有病率の増加により、MEA 地域の放射性医薬品市場は予測期間中に大幅な成長を遂げると予想されます。

新型コロナウイルス感染症 (COVID-19) の場合、MEA は大きな影響を受ける特に南アフリカ。中東の国々も、新型コロナウイルス感染症のパンデミックによって社会経済状況に広く影響を受けています。しかし、各国は感染拡大を避けるために、新型コロナウイルス感染症のパンデミックに賢明に対応してきました。他の地域と同様に、ロックダウンと社会的距離が課され、これらの傾向が損なわれ、仕事、定期収入、支払い、見本市、学校、医療へのアクセスが妨げられました。したがって、各国は巨額の損失を被っており、現在もその損失を回復しようとしていると予想される。ロックダウンは地域の非緊急医療サービスに広範囲に影響を及ぼし、医療機器にも影響を与えている。サウジアラビアやUAEなどの国が、この地域の医療目的地として台頭しつつある。しかし、資源は各国に依存しています。この地域の発展途上国でワクチンやその他の医療施設が利用可能になったことにより、数年間は市場に余地が提供されると予想されます。新型コロナウイルス感染症のパンデミックは、上記の国々が医療サービスの能力を強化し、その能力を発揮するのに役立っています。サウジアラビアでは、一般的な神経疾患の来院数が 24% 減少しました。パンデミック前とパンデミック期間全体との比較。最も顕著な例は脳CTスキャンで、流行期間中に11.3％増加した。救急外来の受診が減少している主な原因の1つは、病院を受診するだけで新型コロナウイルス感染症に感染するのではないかという恐怖です。これらの要因は、市場の成長にマイナスの影響を与える可能性があります。

市場の概要とダイナミクス

MEA 放射性医薬品市場は、2021 年の 3 億 8,120 万米ドルから 2028 年までに 6 億 3,978 万米ドルに成長すると予想されています。 2021 年から 2028 年にかけて 7.7% の CAGR で成長すると推定されています。PET と SPECT が疾患の検出、位置特定、特性評価の精度を向上させ続けるにつれて、核医学処置の使用は急速に拡大しています。 PET と SPECT は、臨床現場で使用される核医学放射線療法の 1 つです。核医学会によると、毎年、この地域の国々で疾患を診断し、標的を絞った治療を提供するために、放射性医薬品と画像診断装置を使用して数百万件の核医学処置が行われています。これらの技術は、免疫学、感染症、消化器病学、心臓病学、腫瘍学、神経学、精神医学などの分野でも診断やその他の用途に採用されています。高度な核医学と最新の画像機器は、医師がより適切な方法で、より短時間で病気を診断できるように支援しています。 PET/CTおよびSPECT/CTプラットフォーム用の新しい放射性医薬品の継続的な開発は、神経学や整形外科などの新しい臨床用途に使用され、さまざまな腫瘍病期分類法の精度の向上とともに、市場の成長にさらに貢献しています。 2020年9月、キュリウムは、成人患者におけるソマトスタチン受容体陽性神経内分泌腫瘍（NET）の局在を示す陽電子放出断層撮影（PET）剤であるDetectnetを発売した。したがって、核イメージング技術の品質と有効性を向上させる技術の進歩は、MEA 放射性医薬品市場の成長を促進しています。

主要な市場セグメント

タイプの点では、2020 年の MEA 放射性医薬品市場で診断用核医学セグメントが最大のシェアを占めました。アプリケーションの点では、2020 年の MEA 放射性医薬品市場で腫瘍学セグメントがより大きな市場シェアを占めました。さらに、2020 年のエンドユーザーベースの MEA 放射性医薬品市場では、病院セグメントがより大きなシェアを占めていました。

上場されている主要供給源と企業

MEA 放射性医薬品市場に関するこのレポートを作成するために参照されたいくつかの主要な一次および二次情報源は、企業の Web サイト、年次報告書、財務報告書、政府文書、統計データベースなどです。レポートに記載されている主要企業は、Advanced Accelerator Applications、Bayer AG、Bracco Imaging SpA、Cardinal Health Inc、Curium、ECZACIBA?I MONROL NUCLEAR PRODUCTS CO.、GENERAL ELECTRIC、Nordion、NTP RADIOISOTOPESです。

購入理由レポート

MEA 放射性医薬品市場の状況を理解し、高い収益を保証する可能性が最も高い市場セグメントを特定する
MEA 放射性医薬品市場の絶え間なく変化する競争環境を理解することで、競争に先んじる
売上が最も見込める市場セグメントを特定することで、MEA 放射性医薬品市場における M&A やパートナーシップ取引を効率的に計画
さまざまなセグメントの市場パフォーマンスの知覚的かつ包括的な分析から、知識に基づいたビジネス上の意思決定を行うのに役立ちますMEA 放射性医薬品市場の形成
MEA 地域における 2021 年から 2028 年までのさまざまなセグメント別の市場収益予測を取得します。

MEA 放射性医薬品市場セグメンテーション

MEA 放射性医薬品市場 -タイプ別

核診断医学
- SPECT
- PET
治療用核医学
- アルファ放射体
- ベータ放射体
- 近接照射療法同位体

< p>MEA 放射性医薬品市場 - 用途別

腫瘍学
心臓病学
神経学
その他

MEA 放射性医薬品市場 - >エンドユーザー別

病院
画像センター
学術および研究センター ;
その他

MEA 放射性医薬品市場 - 国別

サウジアラビア
南アフリカ
アラブ首長国連邦
MEA のその他の地域

MEA 放射性医薬品市場 - 会社概要

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 MEA Radiopharmaceuticals Market – By Type

1.3.2 MEA Radiopharmaceuticals Market – By Application

1.3.3 MEA Radiopharmaceuticals Market – By End User

1.3.4 MEA Radiopharmaceuticals Market– By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. MEA Radiopharmaceuticals Market– Market Landscape

4.1 Overview

4.2 MEA PEST Analysis

4.3 Experts Opinion

5. MEA Radiopharmaceuticals Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Escalation in the Usage of Alpha Radio Immunotherapy

5.1.2 Surging Advancements in Nuclear Imaging Techniques

5.2 Market Restraints

5.2.1 Accessibility of Substitutes

5.3 Market Opportunities

5.3.1 Growth Potential in Several Countries

5.4 Future Trends

5.4.1 Burgeoning Usage of Nuclear Medicines for Personalized Treatment

5.5 Impact Analysis

6. Radiopharmaceuticals Market– MEA Analysis

6.1 MEA Radiopharmaceuticals Market Revenue Forecast and Analysis

7. MEA Radiopharmaceuticals Market Analysis – By Type

7.1 Overview

7.2 MEA Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)

7.3 Diagnostic Nuclear Medicine

7.3.1 Overview

7.3.2 Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3 SPECT

7.3.3.1 Overview

7.3.3.2 SPECT: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4 PET

7.3.4.1 Overview

7.3.4.2 PET: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Therapeutic Nuclear Medicine

7.4.1 Overview

7.4.2 Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3 Alpha Emitters

7.4.3.1 Overview

7.4.3.2 Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4 Beta Emitters

7.4.4.1 Overview

7.4.4.2 Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.5 Brachytherapy Isotopes

7.4.5.1 Overview

7.4.5.2 Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8. MEA Radiopharmaceuticals Market Analysis – By Application

8.1 Overview

8.2 MEA Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)

8.3 Oncology

8.3.1 Overview

8.3.2 Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Cardiology

8.4.1 Overview

8.4.2 Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Neurology

8.5.1 Overview

8.5.2 Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9. MEA Radiopharmaceuticals Market Analysis – By End User

9.1 Overview

9.2 MEA Radiopharmaceuticals Market Share, by End User, 2021 and 2028, (%)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Imaging Centres

9.4.1 Overview

9.4.2 Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Academic and Research Centers

9.5.1 Overview

9.5.2 Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

10. MEA Radiopharmaceuticals Market – Country Analysis

10.1 MEA: Radiopharmaceuticals Market

10.1.1 Overview

10.1.2 MEA: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)

10.1.2.1 Saudi Arabia: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.1 Saudi Arabia: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.2 Saudi Arabia Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2.1 Saudi Arabia: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.1.2.2 Saudi Arabia: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.1.3 Saudi Arabia Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

10.1.2.1.4 Saudi Arabia Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

10.1.2.2 UAE: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.1 UAE: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.2 UAE Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2.1 UAE: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.2.2.2 UAE a: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.2.3 UAE Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

10.1.2.2.4 UAE Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.2.3 South Africa: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.1 South Africa: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.2 South Africa Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2.1 South Africa: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.3.2.2 South Africa: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.3.3 South Africa Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

10.1.2.3.4 South Africa Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.2.4 Rest of MEA: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.1 Rest of MEA: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.2 Rest of MEA Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.4.2.1 Rest of MEA: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.4.2.2 Rest of MEA: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.4.3 Rest of MEA Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

10.1.2.4.4 Rest of MEA Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

11. Impact Of COVID-19 Pandemic on MEA Radiopharmaceuticals Market

11.1 MEA: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Inorganic Growth Strategies

12.2.1 Overview

12.3 Organic Growth Strategies

12.3.1 Overview

13. Company Profiles

13.1 Cardinal Health Inc

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Curium

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 GENERAL ELECTRIC

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Bayer AG

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Bracco Imaging S.p.A

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 ECZACIBA?I MONROL NUCLEAR PRODUCTS CO.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Nordion

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 NTP RADIOISOTOPES

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Advanced Accelerator Applications

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. MEA Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Table 2. Saudi Arabia Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 3. Saudi Arabia Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 4. Saudi Arabia Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 5. Saudi Arabia Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 6. Saudi Arabia Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 7. UAE Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 8. UAE Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 9. UAE Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 10. UAE Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 11. UAE Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 12. South Africa Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 13. South Africa Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 14. South Africa Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 15. South Africa Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 16. South Africa Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 17. Rest of MEA Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 18. Rest of MEA Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 19. Rest of MEA Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 20. Rest of MEA Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 21. Rest of MEA Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 22. Recent Inorganic Growth Strategies

Table 23. Recent Organic Growth Strategies

Table 24. Glossary of Terms

LIST OF FIGURES

Figure 1. MEA Radiopharmaceuticals Market Segmentation

Figure 2. MEA Radiopharmaceuticals Market Segmentation, By Country

Figure 3. MEA Radiopharmaceuticals Market Overview

Figure 4. Diagnostic Nuclear Medicine Segment Held the Largest Share of the Market in 2021

Figure 5. Saudi Arabia to Show Significant Growth During Forecast Period

Figure 6. MEA PEST Analysis

Figure 7. MEA Radiopharmaceuticals Market Impact Analysis of Drivers and Restraints

Figure 8. MEA Radiopharmaceuticals Market– Revenue Forecast and Analysis

Figure 9. MEA Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)

Figure 10. MEA Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11. MEA SPECT: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. MEA PET: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. MEA Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. MEA Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. MEA Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. MEA Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. MEA Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)

Figure 18. MEA Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. MEA Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. MEA Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. MEA Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. MEA Radiopharmaceuticals Market Share, by End User, 2021 and 2028 (%)

Figure 23. MEA Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. MEA Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. MEA Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. MEA Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. MEA: Radiopharmaceuticals Market, by Key Country – Revenue (2021) (USD Million)

Figure 28. MEA: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)

Figure 29. Saudi Arabia: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

Figure 30. UAE: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

Figure 31. South Africa: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

Figure 32. Rest of MEA: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

Figure 33. Impact of COVID-19 Pandemic in MEA Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the MEA radiopharmaceuticals market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the MEA radiopharmaceuticals market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the radiopharmaceuticals market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Middle East and Africa Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and S..	May 2022
Middle East and Africa Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, En..	May 2022
Middle East and Africa In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe M..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample